Global Osteoporosis Diet and Nutrition Market size (2023-2030)

The global Osteoporosis Diet and Nutrition Market size is estimated to grow from USD 700 Million in 2022 to USD 980.33 Million by 2030. The market is witnessing a healthy CAGR of 4.3 % from 2023 to 2030. The high incidence of Osteoporosis patients is the major factor that is driving the growth of the industry.

Industry Overview

Osteoporosis is characterized by a reduction in the density and first-class of bones that regularly result in damaged bones in the wrist, hip, and spine. Various elements accountable for osteoporosis include genetic factors, low consumption of calcium, magnesium, and nutrition D, consuming issues such as anorexia, inaction and immobility, and immoderate alcohol intake. Moreover, prerequisites that expand the danger of osteoporosis include cancer, persistent kidney diseases, persistent obstructive pulmonary disease, and some autoimmune illnesses such as rheumatoid arthritis.

Recent research has discovered that olive oil, soybeans, blueberries, and foods prosperous in omega-3s, like fish oil and flaxseed oil, can also additionally have bone-boosting benefits. While extra research is wanted before the link between these meals and bone fitness can definitively be made, the many overall health advantages of these foods make them extraordinary preferences to add to your diet. Studies have additionally proven that reasonable consumption of positive alcoholic and non-alcoholic liquids like wine, beer, and tea may additionally be exact for your bones. More research is additionally wanted to higher assist us to higher apprehend the relationship between these drinks and bone health.

The bones grow to be porous in this medical condition, which makes them extra fragile and, in turn, susceptible to fractures, caused by the over manufacturing of the hormone parathyroid. Osteoporosis additionally takes place owing to a variety of illnesses or treatments, which consists of anorexia, alcoholism, kidney disease, hyperthyroidism, and surgical elimination of the ovaries. Certain medicinal drugs also assist to extend the price of bone loss, which includes some anti-seizure medications, proton pump inhibitors, chemotherapy, selective serotonin reuptake inhibitors, and glucocorticosteroids.

COVID-19 impact on the Osteoporosis Diet and Nutrition Market

The COVID-19 pandemic badly hit the world and it also affected the drinks market in a very large aspect. Especially the laminate market was badly hit by the pandemic. COVID-19 is an infectious sickness that originated in the Hubei province of Wuhan town in China in late December. The highly contagious disease, prompted by a virus, extreme acute respiratory syndrome coronavirus two (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the ailment has unfolded to nearly 213 international locations around the globe with the World Health Organization declaring it a public fitness emergency on March 11, 2020.

In the context of COVID-19, government agencies in various countries, lookup institutes, and many biotech and pharmaceutical companies are focusing on tremendous and fast technologies for the fast prognosis of COVID-19. Automobile production has been disrupted, ensuing in a massive loss in the entire automotive sector. For instance, the number of passenger automobiles registered in the European Union declined by 53.4 % to 526,645 devices in the second quarter of 2020, The demand for neopentyl glycol has lowered dramatically as the functioning of the car area has deteriorated, for this reason impacting the market increase in various countries.

MARKET DRIVERS:

The high incidence of Osteoporosis Patients is driving the growth of the market

During the forecast period, rising osteoporosis prevalence and incidence are anticipated to fuel market expansion. For instance, according to the INTERNATIONAL OSTEOPOROSIS FOUNDATION, osteoporosis results in one fracture due to the disease every 3 seconds and more than 8.9 billion fractures per year worldwide.

MARKET RESTRAINTS:

The high cost of the diet and other dietary supplies is restraining the growth of the market

The high cost of the diet and other dietary supplies is restraining the growth of the market during the forecast period. Weakening of bones is a very serious condition that can be treated about 80% only by maintaining a good diet but the edible items required in large quantities throughout the treatment period may not be affordable by many patients which restrains the growth of the market.

OSTEOPOROSIS DIET AND NUTRITION MARKET REPORT COVERAGE:

This research report on the global Osteoporosis Diet and Nutrition Market has been segmented and sub-segmented based on Gender, and region.

Osteoporosis Diet and Nutrition Market   - By Gender:

• Male
• Female
• Others

By Gender, On the basis of Gender, the female section held an important share of the market in terms of revenue. The cause would possibly be attributed to an upsurge in incidence as an end result of menopause in women. According to a report posted by International Osteoporosis Foundation, it states that almost 30% of all postmenopausal girls have an extended rate of osteoporosis owing to low bone mass amongst 200 million human beings worldwide.

Moreover, in accordance with the National Institutes of Health Osteoporosis and Related Bone Diseases, lifestyle-related elements such as alcohol abuse, sedentary lifestyle, and smoking is determined to promote this circumstance in a lady more than in a male. Osteoporosis Drugs income is believed to rise successfully as the aforementioned aspect poses the excessive medical urgency to curb osteoporosis and is predicted to in addition enlarge the consumption price over the projection length of 2023-2028.

Osteoporosis Diet and Nutrition Market - By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East
• Africa

Geographically, North America dominated the Osteoporosis Diet and Nutrition Market with a share of 37% in 2022. North America stays the greatest consumer of Osteoporosis Diet and Nutrition owing to the excessive occurrence of osteoporosis patients in the region, set up healthcare infrastructure, availability of branded capsules coupled with the presence of key players which continues to enlarge its market. High preliminary capital funding on R&D investing in drug discovery and improvement and growing healthcare expenditure, really helpful authorities’ initiatives alongside with growing quantity of lookup partnerships with key gamers are to cater the Osteoporosis Diet and Nutrition Market in the forecast length of 2023-2030.

Europe is estimated to flourish subsequent to North America considering the osteoporosis remedy owing to new drug launches, lively authorities support, and others. For instance, the European Commission accepted the drug named EVENITY (romosuzumab) for the therapy of extreme osteoporosis in women. Thus, authorities' interest to create consciousness and manufacturers’ interest to enlarge the market throughout the globe has spurred the demand for the capsules in the particular location triggering the increase of the market. According to the International Osteoporosis Foundation in 2015, the occurrence of osteoporosis over the age of 50 and above in France is mentioned to be 6.9% in men and 22.7% in women. In Germany, the occurrence of osteoporosis amongst guys struggling with osteoporosis is 6.7% and amongst ladies it is 22.5%, thereby augmenting the demand for osteoporosis therapy.

The market in the Asia Pacific is anticipated to develop at the best CAGR. The increase in the CAGR is characterized by the aid of a rise in the geriatric patient pool struggling with osteoporosis, enlarge in the adoption of the new drug for the therapy of osteoporosis, and others. Also, economically creating nations such as China and India are regarded as the principal contributors to healthcare expenditure, which is anticipated to end result in the best CAGR in the region.

The market in Latin America and the Middle East & Africa place is at the nascent stage owing to accelerated healthcare infrastructure, a rise in awareness amongst the population, and others.

Osteoporosis Diet and Nutrition Market Share by Company

1. Merck & Co. Inc.
2. Radius Health Inc.
3. Novartis AG
4. Eli Lilly and Company
5. Pfizer Inc.
6. Amgen Inc.
7. Novo Nordisk A/S
8. F. Hoffmann-La Roche Ltd.
9. UCB S.A.
10. Teva Pharmaceutical Industries Ltd.

Mergers and acquisitions in the enterprise have enabled players to diversify and decorate their carrier services.

Recently, Dr. Reddy’s Laboratory announced the launch of an Osteoporosis Drug Raloxifene in the U.S. for the treatment of osteoporosis, which was rolled out to expand the treatment options and gain a competitive advantage.

The market is highly fragmented. Prominent market players are pursuing a number of strategies, such as strategic joint ventures and partnership agreements, product innovations, lookup & development initiatives, geographical expansions, and mergers & acquisitions, to improve their foothold in the industry. They are especially focusing on providing cloud-based or on-premise options to giant enterprises to allow environment-friendly and effective money transfers in real time. Vendors are additionally focusing on increasing their product choices to enhance the consumer experience.

NOTABLE HAPPENINGS IN THE GLOBAL OSTEOPOROSIS DIET AND NUTRITION MARKET IN THE RECENT PAST:

• Product Launch - In May 2021, Theramex, a London-headquartered pharmaceutical company, launched the osteoporosis medicine Livogiva in Europe.